A study to test how BI 456906 is taken up in the blood of people with and without kidney problems
1404-0009
Phase 1 other active
Quick answer
A study to test how BI 456906 is taken up in the blood of people with and without kidney problems for Renal impairment (mild, moderate and severe), Healthy is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Renal impairment (mild, moderate and severe), Healthy
- Phase
- Phase 1
- Modality
- other
- Status
- active